Internal Medicine, Hematology & Oncology · Aurora, CO
NPI
1861539751
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
12401 E 17th Ave
Aurora, CO, 80045
Phone (720) 848-4289
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
409 services
Medicare patients, 2024
129
Average age 70
Drug cost, 2024
$1.3M
474 prescriptions
Company payments, 2025
$3,557
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Breelyn A Wilky was code 99214 (office e&m - established), 133 times for 67 patients. In total Breelyn A Wilky billed 409 services in 13 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 133 | 67 | $73.72 | $9,804 |
| 99214 Office E&M - Established | Office | 121 | 59 | $97.74 | $12K |
| 99443 Telephone Services | Facility | 50 | 22 | $73.71 | $3,685 |
| 99215 Office E&M - Established | Facility | 41 | 28 | $114.00 | $4,674 |
| 99215 Office E&M - Established | Office | 19 | 11 | $134.67 | $2,559 |
| 99205 Office E&M - New | Facility | 11 | 11 | $114.29 | $1,257 |
By year: 2022 $32K for 350 services; 2023 $26K for 318 services; 2024 $36K for 409 services.
Medicare prescription drug claims, 2024
In 2024, the drug Breelyn A Wilky prescribed most often to Medicare patients was Imatinib Mesylate, with 37 prescriptions and refills. In total Breelyn A Wilky wrote 474 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 37 | 37 | Under 11 | $3,655 |
| Sunitinib Malate Generic | 35 | 36 | Under 11 | $222K |
| Dexamethasone Generic | 26 | 26 | 11 | $881 |
| Oxycodone Hcl Generic | 23 | 24 | Under 11 | $215 |
| Gleevec Imatinib Mesylate | 22 | 22 | Under 11 | $144K |
| Prochlorperazine Maleate Generic | 16 | 16 | 13 | $129 |
| Ondansetron Odt Ondansetron | 16 | 16 | Under 11 | $409 |
| Ondansetron Hcl Generic | 16 | 16 | 14 | $82.05 |
| Prednisone Generic | 14 | 14 | Under 11 | $52.82 |
| Gabapentin Generic | 13 | 13 | Under 11 | $98.5 |
| Ogsiveo Nirogacestat Hydrobromide | 12 | 12 | Under 11 | $337K |
| Pazopanib Hcl Generic | 11 | 11 | Under 11 | $79K |
| Methylprednisolone Generic | 11 | 11 | Under 11 | $68.56 |
| Celecoxib Generic | 11 | 11 | Under 11 | $2,101 |
Brand drugs: - claims; generic drugs: 376 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Breelyn A Wilky $3,557 ($3,557 in general payments such as food, travel and fees) from 5 companies. The largest payer was Deciphera Pharmaceuticals Inc. with $3,183.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.